Fundies. English
Segment disclosures
Company overview삼익제약
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
1 dimension combinations 15 retained observations 10 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Consolidated
Consolidated And Separate Financial Statements
Source dimensions
ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 15702065312 | KRW | 20260814 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 31210833399 | KRW | 20260814 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 15508768087 | KRW | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 60020414513 | KRW | 20260320 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 15813871295 | KRW | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 44782738683 | KRW | 20251114 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 14920216187 | KRW | 20260814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 28968867388 | KRW | 20260814 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 14048651201 | KRW | 20260515 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 55857374361 | KRW | 20260320 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 14222980161 | KRW | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 41764702488 | KRW | 20251114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 14229756255 | KRW | 20251031 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 27541722327 | KRW | 20251031 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 51228980608 | KRW | 20260320 | Open filing evidence |